Advertisement

Topics

Janssen Biotech Release: DARZALEX (daratumumab) Approved By The U.S. FDA In Combination With Pomalidomide And Dexamethasone For Patients With Multiple Myeloma Who Have Received At Least Two Prior Therapies

20:00 EDT 18 Jun 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Janssen Biotech Release: DARZALEX (daratumumab) Approved By The U.S. FDA In Combination With Pomalidomide And Dexamethasone For Patients With Multiple Myeloma Who Have Received At Least Two Prior Therapies

NEXT ARTICLE

More From BioPortfolio on "Janssen Biotech Release: DARZALEX (daratumumab) Approved By The U.S. FDA In Combination With Pomalidomide And Dexamethasone For Patients With Multiple Myeloma Who Have Received At Least Two Prior Therapies"

Advertisement
Quick Search
Advertisement
Advertisement